
Christopher M. Polley
Examiner (ID: 17176, Phone: (571)270-5734 , Office: P/1785 )
| Most Active Art Unit | 1785 |
| Art Unit(s) | 1785 |
| Total Applications | 782 |
| Issued Applications | 530 |
| Pending Applications | 72 |
| Abandoned Applications | 201 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14716271
[patent_doc_number] => 20190249199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => METHODS AND PRODUCTS FOR PRODUCING ENGINEERED MAMMALIAN CELL LINES WITH AMPLIFIED TRANSGENES
[patent_app_type] => utility
[patent_app_number] => 16/258207
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23474
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16258207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/258207 | METHODS AND PRODUCTS FOR PRODUCING ENGINEERED MAMMALIAN CELL LINES WITH AMPLIFIED TRANSGENES | Jan 24, 2019 | Abandoned |
Array
(
[id] => 14413415
[patent_doc_number] => 20190172551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => ALGORITHMS FOR DISEASE DIAGNOSTICS
[patent_app_type] => utility
[patent_app_number] => 16/248074
[patent_app_country] => US
[patent_app_date] => 2019-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16248074
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/248074 | ALGORITHMS FOR DISEASE DIAGNOSTICS | Jan 14, 2019 | Abandoned |
Array
(
[id] => 14185753
[patent_doc_number] => 20190112581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => Host Cell Modification with Artificial Endosymbionts
[patent_app_type] => utility
[patent_app_number] => 16/225610
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16225610
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/225610 | Host Cell Modification with Artificial Endosymbionts | Dec 18, 2018 | Abandoned |
Array
(
[id] => 16961914
[patent_doc_number] => 20210213413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => SYSTEMS AND METHODS FOR MULTIPLEXED MEASUREMENTS IN SINGLE AND ENSEMBLE CELLS
[patent_app_type] => utility
[patent_app_number] => 16/967402
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57546
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967402
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967402 | Systems and methods for multiplexed measurements in single and ensemble cells | Dec 18, 2018 | Issued |
Array
(
[id] => 14842737
[patent_doc_number] => 20190279769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => METHODS AND COMPOSITIONS RELATED TO TRIPLE-NEGATIVE BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 16/217350
[patent_app_country] => US
[patent_app_date] => 2018-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16217350
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/217350 | Methods and compositions related to triple-negative breast cancer | Dec 11, 2018 | Issued |
Array
(
[id] => 14497807
[patent_doc_number] => 20190192558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => METHODS AND COMPOSITIONS FOR GENETIC MODULATION
[patent_app_type] => utility
[patent_app_number] => 16/212096
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16212096
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/212096 | Methods and compositions for genetic modulation | Dec 5, 2018 | Issued |
Array
(
[id] => 17666419
[patent_doc_number] => 11360104
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => Microbial-based biosensors
[patent_app_type] => utility
[patent_app_number] => 16/209678
[patent_app_country] => US
[patent_app_date] => 2018-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 77
[patent_figures_cnt] => 123
[patent_no_of_words] => 41225
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 370
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16209678
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/209678 | Microbial-based biosensors | Dec 3, 2018 | Issued |
Array
(
[id] => 17922838
[patent_doc_number] => 11466071
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => HLA class I-restricted t cell receptors against mutated RAS
[patent_app_type] => utility
[patent_app_number] => 16/769144
[patent_app_country] => US
[patent_app_date] => 2018-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 15980
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16769144
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/769144 | HLA class I-restricted t cell receptors against mutated RAS | Dec 2, 2018 | Issued |
Array
(
[id] => 20506082
[patent_doc_number] => 12540352
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-03
[patent_title] => Method for detecting nucleic acid
[patent_app_type] => utility
[patent_app_number] => 17/278201
[patent_app_country] => US
[patent_app_date] => 2018-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 67
[patent_no_of_words] => 5429
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17278201
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/278201 | Method for detecting nucleic acid | Nov 29, 2018 | Issued |
Array
(
[id] => 14404341
[patent_doc_number] => 20190168014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => OPTOGENETIC CONTROL OF ENDOTHELIAL CELLS
[patent_app_type] => utility
[patent_app_number] => 16/198217
[patent_app_country] => US
[patent_app_date] => 2018-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16198217
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/198217 | OPTOGENETIC CONTROL OF ENDOTHELIAL CELLS | Nov 20, 2018 | Abandoned |
Array
(
[id] => 14897569
[patent_doc_number] => 20190292550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
[patent_app_type] => utility
[patent_app_number] => 16/178551
[patent_app_country] => US
[patent_app_date] => 2018-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52135
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16178551
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/178551 | CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION | Oct 31, 2018 | Abandoned |
Array
(
[id] => 14343007
[patent_doc_number] => 20190153476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => CRISPR-CAS SYSTEMS FOR ALTERING EXPRESSION OF GENE PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 16/177403
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16177403
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/177403 | CRISPR-CAS SYSTEMS FOR ALTERING EXPRESSION OF GENE PRODUCTS | Oct 30, 2018 | Pending |
Array
(
[id] => 17998067
[patent_doc_number] => 11499163
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-15
[patent_title] => Expression method of Haemocoagulase Acutus (Halase) recombinant protein
[patent_app_type] => utility
[patent_app_number] => 16/175812
[patent_app_country] => US
[patent_app_date] => 2018-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2487
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16175812
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/175812 | Expression method of Haemocoagulase Acutus (Halase) recombinant protein | Oct 29, 2018 | Issued |
Array
(
[id] => 14868665
[patent_doc_number] => 20190284574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => Stable Production of Lentiviral Vectors
[patent_app_type] => utility
[patent_app_number] => 16/166459
[patent_app_country] => US
[patent_app_date] => 2018-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16166459
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/166459 | Stable Production of Lentiviral Vectors | Oct 21, 2018 | Abandoned |
Array
(
[id] => 19027306
[patent_doc_number] => 11926653
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-12
[patent_title] => Methods and materials for NT-3 gene therapy
[patent_app_type] => utility
[patent_app_number] => 16/757176
[patent_app_country] => US
[patent_app_date] => 2018-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 10
[patent_no_of_words] => 35710
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757176
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/757176 | Methods and materials for NT-3 gene therapy | Oct 18, 2018 | Issued |
Array
(
[id] => 16541297
[patent_doc_number] => 20200407710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => METHODS FOR HIGH-RESOLUTION GENOME-WIDE FUNCTIONAL DISSECTION OF TRANSCRIPTIONAL REGULATORY REGIONS
[patent_app_type] => utility
[patent_app_number] => 16/757296
[patent_app_country] => US
[patent_app_date] => 2018-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44535
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757296
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/757296 | Methods for high-resolution genome-wide functional dissection of transcriptional regulatory regions | Oct 16, 2018 | Issued |
Array
(
[id] => 15194279
[patent_doc_number] => 10494621
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-03
[patent_title] => Crispr enzyme mutations reducing off-target effects
[patent_app_type] => utility
[patent_app_number] => 16/158295
[patent_app_country] => US
[patent_app_date] => 2018-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 71
[patent_figures_cnt] => 71
[patent_no_of_words] => 249830
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16158295
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/158295 | Crispr enzyme mutations reducing off-target effects | Oct 10, 2018 | Issued |
Array
(
[id] => 14808869
[patent_doc_number] => 20190271044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => METHODS FOR SEQUENCING SAMPLES
[patent_app_type] => utility
[patent_app_number] => 16/154307
[patent_app_country] => US
[patent_app_date] => 2018-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22456
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16154307
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/154307 | Methods for sequencing samples | Oct 7, 2018 | Issued |
Array
(
[id] => 17587954
[patent_doc_number] => 11326212
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => Biomarkers for non-hodgkin lymphomas and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/148576
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 6
[patent_no_of_words] => 24920
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16148576
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/148576 | Biomarkers for non-hodgkin lymphomas and uses thereof | Sep 30, 2018 | Issued |
Array
(
[id] => 14185327
[patent_doc_number] => 20190112368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => METHODS OF PRODUCING TWO CHAIN PROTEINS IN BACTERIA
[patent_app_type] => utility
[patent_app_number] => 16/138180
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16138180
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/138180 | Methods of producing two chain proteins in bacteria | Sep 20, 2018 | Issued |